Latest News and Press Releases

ESO released the 2026 ESO EMS Index, the annual benchmark for prehospital care built on the industry’s largest integrated emergency outcome data asset.

Final results confirm and build on interim BIRCH results in 23 ICH patients Primary safety endpoint met with no mortality observedEncouraging efficacy signals on all clinical and biomarker endpoints...

Freiburg, Germany, April 29, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™...

Final results of BIRCH multicenter, randomized, open-label Phase 2a proof-of-concept BIRCH trial with 23 patients, conducted in BelgiumFinal results build on positive second interim results announced...

Freiburg, Germany, April 23, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle...

Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with...

Centre for Neuro Skills earns second consecutive spot on Newsweek’s America’s Greatest Midsize Workplaces in Health Care 2026 list.

Freiburg, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), today announced that the U.S. Food and Drug Administration (FDA)...

WallabyPhenox completes financing to strengthen its balance sheet, support global expansion, and advance major neurovascular clinical programs.

IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Toro Neurovascular today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Toro 88 Superbore...